Axxam Investor
Axxam is focused on the development of small molecule drugs with the ability to target inflammation directly.
Headquarters:
Italy
Last Funding Date:
2015-01-05
Total Funding:
340000 USD
Last Funding Type:
Grant
Founded Date:
2011-01-01
Industry:
Biotechnology, Health Care, Science and Engineering
Employee Number:
51-100
Estimated Revenue:
Less than $1M